Argent Advisors’s AtriCure ATRC Stock Holding History

Argent Advisors’s Portfolio ATRC Stock Details ATRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-209	Closed	-$6K	–	148
2019 Q4	$6K	Buy	+209	New	+$5.95K	﹤0.01%	349

Other funds holding ATRC

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Argent Advisors's ATRC Position: Q1 2020 in Review

Argent Advisors sold out of AtriCure (ATRC) in Q1 2020, closing a stake of 209 shares — an estimated $6K sold.

Argent Advisors first reported a position in ATRC in Q4 2019 and held it in 1 quarter. The position peaked at $6K in Q4 2019. 155 funds tracked by Wall St. Rank hold ATRC as of Q1 2020.

Argent Advisors reported no remaining AtriCure position as of Q1 2020 after selling out during the quarter.
Argent Advisors sold 209 AtriCure shares in Q1 2020, an estimated $6K.
Argent Advisors first reported a position in AtriCure in Q4 2019 and held it in 1 quarter.
Argent Advisors's AtriCure position peaked at $6K in Q4 2019.
155 funds tracked by Wall St. Rank held AtriCure as of Q1 2020.

Based on Argent Advisors's 13F filing for Q1 2020, filed 23 Apr 2020.